Damas François, Nguyen Trung Mai-Linh, Postolache Adriana, Petitjean Hélène, Lempereur Mathieu, Viva Tommaso, Oury Cécile, Dulgheru Raluca, Lancellotti Patrizio
Department of Cardiology, CHU Sart Tilman, GIGA Cardiovascular Sciences Liège, University of Liège Hospital, 4000 Liège, Belgium.
Department of Minimally Invasive Cardiac Surgery, University of Milan, 20122 Milan, Italy.
J Clin Med. 2024 Jan 11;13(2):409. doi: 10.3390/jcm13020409.
Recently, a staging system using 4 grades has been proposed to quantify the extent of cardiac damage associated with aortic stenosis (AS), namely AS-related cardiac damage staging (ASCDS). ASCDS is independently associated with all-cause mortality and important clinical outcomes. To evaluate whether it might be associated with the occurrence of conduction system disorders after TAVI, a total of 119 symptomatic patients with severe AS who underwent a TAVI were categorized according to ASCDS: group 1 (13.5%): no or LV damage; group 2 (58.8%): left atrial/mitral valve damage, atrial fibrillation (AF); group 3 (27.7%): low-flow state, pulmonary vasculature/tricuspid valve/RV damage. After TAVI, 34% of patients exhibited LBBB and 10% high-degree atrioventricular block (HD-AVB). No patient in group 1 developed HD-AVB whereas new LBBB was frequent in groups 2 and 3. Twenty-one patients presented with paroxysmal AF with a higher rate for each group increment (group 1: = 0, 0%; group 2: = 11, 15.7%; group 3: = 10, 30.3%) ( = 0.012). Patients in group 3 had the higher rate of permanent pacemaker implantation (PPMI) (group 1: = 1, 6.3%; group 2: = 7, 10%; group 3: = 9, 27.3%) ( = 0.012). In conclusion, ASCDS might help identify patients at higher risk of conduction disorders and PPMI requirement after TAVI.
最近,有人提出了一种采用4个等级的分期系统,以量化与主动脉瓣狭窄(AS)相关的心脏损害程度,即AS相关心脏损害分期(ASCDS)。ASCDS与全因死亡率和重要临床结局独立相关。为了评估它是否可能与经导管主动脉瓣置入术(TAVI)后传导系统疾病的发生有关,根据ASCDS对119例接受TAVI的有症状重度AS患者进行了分类:第1组(13.5%):无或左心室损害;第2组(58.8%):左心房/二尖瓣损害、心房颤动(AF);第3组(27.7%):低流量状态、肺血管/三尖瓣/右心室损害。TAVI后,34%的患者出现左束支传导阻滞(LBBB),10%出现高度房室传导阻滞(HD-AVB)。第1组无患者发生HD-AVB,而第2组和第3组新出现LBBB很常见。21例患者出现阵发性AF,每组发生率呈递增趋势(第1组:=0,0%;第2组:=11,15.7%;第3组:=10,30.3%)(=0.012)。第3组患者永久起搏器植入(PPMI)率更高(第1组:=1,6.3%;第2组:=7,10%;第3组:=9,27.3%)(=0.012)。总之,ASCDS可能有助于识别TAVI后传导障碍和PPMI需求风险较高的患者。